Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients. (2016). Farmeconomia. Health Economics and Therapeutic Pathways, 17(1), 7-12. https://doi.org/10.7175/fe.v17i1.1225